Companies / Medicus Pharma Ltd.

Medicus Pharma Ltd.

Nasdaq: MDCXCIK 1997296W. CONSHOHOCKEN, PA

Financials

Revenue
Net income$-47.28M
Total debt$2.34M
Cash$15.17M
Diluted EPS$-2.74
Shares outstanding63.2M

Ownership

63.2M shares outstanding · as of Aug 10, 2026
6.3%Institutions
Ownership
Institutions6.29%3,975,127
Public float93.71%59,205,483

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 2

View all →
Insider% of sharesShares
Smith Andrew AlasdairChief Operating Officer

Institutional holders 23

View all →

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q2 2026
as of
BlackRock, Inc.
13F manager
ExitCommon Stock$-52.5K-34K
-100.00%
low
Q1 2026
as of
Two Sigma Investments, LP
13F manager
ExitCommon Stock$-18.8K-12K
-100.00%
low
Q2 2026
as of
LPL Financial LLC
13F manager
NewCommon Stock$7.8K+18K
17,512
0.03% of shares
low
Q1 2026
as of
Marathon Capital Management
13F manager
NewCommon Stock$7.1K+16K
15,500
0.02% of shares
low
Q2 2026
as of
May Hill Capital, LLC
13F manager
AddCommon Stock$6.7K+15K
+42.11%
50,622
0.08% of shares
low
Q1 2026
as of
Brave Asset Management Inc
13F manager
TrimCommon Stock$-4.6K-10K
-50.00%
10,000
0.02% of shares
low
Q1 2026
as of
Smithfield Trust Co
13F manager
TrimCommon Stock$-1-2K
-17.31%
11,480
0.02% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Bokhari RazaPassive13G/A

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
MDCXCommon StockEquity58471K202BBG01K9HNPW1